FDA Clears Two Treatments for Irritable Bowel Syndrome with Diarrhea – Wall Street Journal


Medscape
FDA Clears Two Treatments for Irritable Bowel Syndrome with Diarrhea
Wall Street Journal
The U.S. Food and Drug Administration has cleared two treatments for irritable bowel syndrome with diarrhea, approving drugs that are both linked to recent merger activity in the sector. Salix Pharmaceuticals Ltd.'s top-selling antibiotic Xifaxan
FDA OKs Eluxadoline and Rifaximin for IBS With DiarrheaMedscape
FDA Approves Treatments for Irritable Bowel Syndrome with DiarrheaPharmacy Times
Actavis: FDA Okays Viberzi To Treat Irritable Bowel Syndrome With DiarrheaRTT News
FDA.gov –MedPage Today
all 33 news articles »

diarrhea – Google News